AMYRIAD THERAPEUTICS
Dead / Abandoned — Abandoned — failure to respond (as of 02 Jan 2026)
What this means for you
This application is over — abandoned 12 Dec 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97107538
- Mark type
- Stylized text
- Filed
- 03 Nov 2021
- Abandoned
- 12 Dec 2025
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, pharmaceutical preparations to treat neurodegenerative diseases; pharmaceuticals, namely, pharmaceutical preparations to attenuate the accumulation of dysfunctional proteins
- Class 042 — Scientific and technological services: Pharmaceutical research and development services; scientific research in the nature of conducting clinical trials in the field of neurodegenerative diseases; scientific research in the nature of conducting clinical trials in the field of dysfunctional protein accumulation; research and development in the field of biotechnology; research and development in the field of biochemistry; information, advisory and consultancy services in relation to all of the foregoing
Owner
- AmyriAD Therapeutics B.V., Los Angeles, CA, NL
Prosecution history
- 02 Jan 2026 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 02 Jan 2026 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 09 Sept 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 09 Sept 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 11 Jun 2025 — NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
- 11 Jun 2025 — INQUIRY TO SUSPENSION E-MAILED
- 11 Jun 2025 — SUSPENSION INQUIRY WRITTEN
- 08 Jun 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 06 Dec 2024 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 06 Dec 2024 — LETTER OF SUSPENSION E-MAILED
- 06 Dec 2024 — SUSPENSION LETTER WRITTEN
- 15 Nov 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 15 Nov 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 Nov 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 14 Aug 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED